Related Experiment Video
Updated: Feb 17, 2026

03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.6K
Risk prediction for chronic atrophic gastritis using a random forest model: A multicenter study.
Hui Cao1, Jing-Lue Han1, Hao Wu2
1Department of Gastroenterology, National Clinical Research Center for Digestive Diseases (Xi'an) Jiangsu Branch, Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi 214000, Jiangsu Province, China.
World Journal of Gastrointestinal Oncology
|February 16, 2026
Summary
A new noninvasive model predicts chronic atrophic gastritis (CAG) risk using key factors like H. pylori infection and age. This tool aids in early identification of high-risk patients for gastric cancer prevention.
Area of Science:
- Gastroenterology and Oncology
- Biostatistics and Machine Learning
- Preventive Medicine
Background:
- Chronic atrophic gastritis (CAG) is a precancerous condition for gastric cancer (GC).
- Current diagnostic methods (gastroscopy, biopsy) are invasive and have limitations.
- Noninvasive tools are needed for early CAG detection.
Purpose of the Study:
- To develop and validate a noninvasive risk prediction model for CAG.
- To identify high-risk individuals for gastric cancer screening.
Main Methods:
- A random forest model was built using multimodal data from 1268 subjects.
- Features included demographics, lifestyle, H. pylori status, and serological markers (PGR).
- Model performance was evaluated using AUC and validated in an external cohort; SHAP analysis was used for interpretation.
Main Results:
- The model identified six key predictors: age, H. pylori infection, PGR, smoking, alcohol, and family history.
- The model achieved high AUCs (0.8542 training, 0.8073 testing, 0.8505 external validation).
- H. pylori infection, age, and PGR were the most influential factors.
Conclusions:
- The random forest model accurately predicts CAG risk noninvasively.
- The model is interpretable and has significant clinical utility for early screening.
- A web-based platform facilitates clinical application.
